The pharma industry, traditionally reliant on measured, demographic-driven advertising strategies, is at the precipice of significant transformation. Nielsen’s latest report on cross-media and audience insights underscores the imperatives for navigating an increasingly fragmented media ecosystem, offering actionable takeaways for pharma media professionals delivering their 2025-2026 campaigns.
Pharma brands accustomed to linear TV as a reliable medium must recognize its evolving partnership with Connected TV (CTV). While linear TV remains a dominant force for live events like sports, CTV’s rapid annual growth rate of 10% confirms its continued rise. The opportunity lies in leveraging these two mediums as complementary forces to maximize audience engagement and ROI.
Pharma marketers are tasked with targeting increasingly specific consumer segments – whether it’s high earners, multicultural audiences, or caregivers. Nielsen’s advanced audience data offers a window into these nuanced groups, showcasing behaviors that extend beyond traditional demographic silos.
The report highlights retail media as an emerging channel, offering unprecedented opportunities for pharma marketers. With closed-loop measurement and behavior-based targeting, this medium aligns perfectly with the need for compliance-driven, measurable advertising strategies in pharma.
With consumers spending an average of 10 hours daily on media, integrating TV with digital platforms is critical. For pharma brands, this means ensuring that advertising narratives are cohesive across channels – balancing compliance needs with creativity.
Live sports remain a goldmine for audience engagement, as evidenced by their dominance in both linear TV and emerging platforms like Netflix. With landmark events like the Olympics and the NFL delivering unparalleled viewership, these programs offer unparalleled visibility for health-related public awareness campaigns.
As the industry transitions to programmatic, addressable marketing, pharma media professionals must adapt by embracing tools and insights that enable precision targeting. Nielsen’s report reinforces the importance of cross-media data to inform decisions, whether negotiating ad placements or measuring campaign impact.
As media converges and consumer expectations evolve, the pharma industry must rise to the occasion with strategies that are data-informed, audience-specific, and contextually relevant.
With the right insights and partnerships, pharma brands can transform these challenges into unparalleled opportunities, ensuring their messaging lands where it matters most – driving health outcomes while optimizing ROI.
To read the full report click here.Â